PSEN1 and melanoma: Thus, these findings suggest that the impaired migration of aggressive melanoma cells treated with the 15 μM DAPT was likely the result of a treatment-induced increase in PS-1, with a subsequent increase P-β-catenin levels leading to reduced Wnt signaling.